Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
FDA approves first treatment for Molybdenum Cofactor Deficiency Type A
The US Food and Drug Administration has approved the first treatment for the rare genetic disorder Molybdenum Cofactor Deficiency Type A.
Santhera Announces Positive Results with Lonodelestat in Early Phase Cystic Fibrosis Trial
PRATTELN, Switzerland I March 1, 2021 I Santhera Pharmaceuticals (SIX.
Coronavirus (COVID-19) Update: FDA Allows More Flexible Storage, Transportation Conditions for Pfizer-BioNTech COVID-19 Vaccine
Today, the U.
Congo confirms three new Ebola cases
GOMA, Democratic Republic of Congo (Reuters) - Three new cases of Ebola have been confirmed in eastern Democratic Republic of Congo, bringing to 11 the number of cases since authorities declar...
FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine
Today, the U.
Japan's Takeda sells four diabetes products to Teijin Pharma for $1.25 billion
TOKYO (Reuters) - Takeda Pharmaceutical Co said on Friday it agreed to sell four diabetes products in Japan to Teijin Pharma Ltd for 133 billion yen ($1.
Pfizer to test third dose, tweaked vaccine to target S.African strain
Concerns have risen that more transmissible coronavirus variants such as the one first detected in South Africa or another in Britain are more resistant to existing vaccines such as the one developed ...
Alzheimer's may strike women and men in different ways
The ravages of Alzheimer's may strike later in women than men, but once it takes hold women tend to deteriorate far faster than men, according to a new study.
AstraZeneca-Amgen drug could widen treatment options for severe asthma
(Reuters) - AstraZeneca and Amgen’s experimental drug reduced asthma attacks in patients with severe and uncontrolled forms of the respiratory condition in a large study, showing promise for...
Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities
SOMERSET, N.
Moderna Announces Additional Capital Investments to Increase Global Manufacturing Capacity for COVID-19 Vaccine
CAMBRIDGE, Mass.
'Night owls' may be twice as likely as morning 'larks' to underperform at work
Night 'owls' may be twice as likely as morning 'larks' to underperform at work and to run a heightened risk of early retirement due to disability, finds research published online in th...
247
248
249
250
251
252
253
254
255
